William Jacot
Impact in
- Oncology top 1%
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 1%
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
Papers in
- Oncology 124
- Cancer Treatment and Pharmacology 40
- HER2/EGFR in Cancer Research 37
- Cancer Cells and Metastasis 13
- Lung Cancer Research Studies 13
-
- Advanced Breast Cancer Therapies 59
- Brain Metastases and Treatment 26
- Co-authors
- Pierre‐Jean Lamy (30 shared papers)Séverine Guiu (32 shared papers)Gilles Romieu (36 shared papers)Catherine Alix‐Panabières (15 shared papers)Simon Thézenas (29 shared papers)Florence Boissière‐Michot (19 shared papers)Caroline Mollévi (21 shared papers)Laure Cayrefourcq (8 shared papers)
- Journals
- Journal of Clinical Oncology (24 papers)Annals of Oncology (19 papers)Cancer Research (16 papers)BMC Cancer (11 papers)ESMO Open (9 papers)
- Partner nations
- FranceUnited StatesItaly
In The Last Decade
William Jacot
207 papers receiving 4.3k citations
William Jacot's Hit Papers
Peers
Comparison fields: 5 of 120
- Oncology 2.2k
- Cancer Research 963
- Pulmonary and Respiratory Medicine 1.1k
- Genetics 265
- Immunology 380
Countries citing papers authored by William Jacot
This map shows the geographic impact of William Jacot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Jacot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Jacot more than expected).
Fields of papers citing papers by William Jacot
This network shows the impact of papers produced by William Jacot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Jacot. The network helps show where William Jacot may publish in the future.
Co-authors
The 25 scholars most cited alongside William Jacot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 227 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 314 | |
| 2 | Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer Hit paper breakdown → | 2024 | 182 |
| 3 | 2009 | 140 | |
| 4 | 2013 | 138 | |
| 5 | 2020 | 119 | |
| 6 | 2011 | 109 | |
| 7 | 2018 | 106 | |
| 8 | 2019 | 92 | |
| 9 | 2020 | 87 | |
| 10 | 2021 | 86 | |
| 11 | 2016 | 83 | |
| 12 | 2003 | 80 | |
| 13 | Trastuzumab deruxtecan (T-DXd) vs physician’s choice of chemotherapy (TPC) in patients (pts) with hormone receptor-positive (HR+), human epidermal growth factor receptor 2 (HER2)-low or HER2-ultralow metastatic breast cancer (mBC) with prior endocrine therapy (ET): Primary results from DESTINY-Breast06 (DB-06). Hit paper breakdown → | 2024 | 60 |
| 14 | 2004 | 60 | |
| 15 | 2001 | 58 | |
| 16 | 2012 | 58 | |
| 17 | 2021 | 57 | |
| 18 | 2014 | 57 | |
| 19 | 2014 | 56 | |
| 20 | 2019 | 56 |
About William Jacot
William Jacot is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Pathology and Forensic Medicine, having authored 227 papers that have together received 4.4k indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (59 papers), Cancer Treatment and Pharmacology (40 papers), Breast Cancer Treatment Studies (38 papers), HER2/EGFR in Cancer Research (37 papers), Brain Metastases and Treatment (26 papers), Cancer Cells and Metastasis (13 papers), Lung Cancer Research Studies (13 papers) and Cancer Genomics and Diagnostics (12 papers). The work is most often cited by research in Oncology (2.2k citations), Cancer Research (963 citations), Pulmonary and Respiratory Medicine (1.1k citations), Genetics (265 citations) and Immunology (380 citations). William Jacot has collaborated with scholars based in France, United States and Italy. Frequent co-authors include Pierre‐Jean Lamy, Séverine Guiu, Gilles Romieu, Catherine Alix‐Panabières, Simon Thézenas, Florence Boissière‐Michot, Caroline Mollévi, Laure Cayrefourcq, Klaus Pantel and Evelyne Lopez‐Crapez. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Research, BMC Cancer and ESMO Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.